-
England 'flat' as Crawley admits Australia a better side
-
Australia four wickets from Ashes glory as England cling on
-
Beetles block mining of Europe's biggest rare earths deposit
-
French culture boss accused of mass drinks spiking to humiliate women
-
NBA champions Thunder suffer rare loss to Timberwolves
-
Burning effigy, bamboo crafts at once-a-decade Hong Kong festival
-
Joshua knocks out Paul to win Netflix boxing bout
-
Dogged Hodge ton sees West Indies save follow-on against New Zealand
-
England dig in as they chase a record 435 to keep Ashes alive
-
Wembanyama 26-point bench cameo takes Spurs to Hawks win
-
Hodge edges towards century as West Indies 310-4, trail by 265
-
US Afghans in limbo after Washington soldier attack
-
England lose Duckett in chase of record 435 to keep Ashes alive
-
Australia all out for 349, set England 435 to win 3rd Ashes Test
-
US strikes over 70 IS targets in Syria after attack on troops
-
Australian lifeguards fall silent for Bondi Beach victims
-
Trump's name added to Kennedy Center facade, a day after change
-
West Indies 206-2, trail by 369, after Duffy's double strike
-
US strikes Islamic State group in Syria after deadly attack on troops
-
Epstein files opened: famous faces, many blacked-out pages
-
Ravens face 'special' Patriots clash as playoffs come into focus
-
Newly released Epstein files: what we know
-
Musk wins US court appeal of $56 bn Tesla pay package
-
US judge voids murder conviction in Jam Master Jay killing
-
Trump doesn't rule out war with Venezuela
-
Haller, Aouar out of AFCON, Zambia coach drama
-
Nasdaq rallies again while yen falls despite BOJ rate hike
-
Bologna win shoot-out with Inter to reach Italian Super Cup final
-
Brandt and Beier send Dortmund second in Bundesliga
-
Trump administration begins release of Epstein files
-
UN Security Council votes to extend DR Congo mission by one year
-
Family of Angels pitcher, club settle case over 2019 death
-
US university killer's mystery motive sought after suicide
-
Rubio says won't force deal on Ukraine as Europeans join Miami talks
-
Burkinabe teen behind viral French 'coup' video has no regrets
-
Brazil court rejects new Bolsonaro appeal against coup conviction
-
Three-time Grand Slam winner Wawrinka to retire in 2026
-
Man Utd can fight for Premier League title in next few years: Amorim
-
Pandya blitz powers India to T20 series win over South Africa
-
Misinformation complicated Brown University shooting probe: police
-
IMF approves $206 mn aid to Sri Lanka after Cyclone Ditwah
-
US halts green card lottery after MIT professor, Brown University killings
-
Stocks advance as markets cheer weak inflation
-
Emery says rising expectations driving red-hot Villa
-
Three killed in Taipei metro attacks, suspect dead
-
Seven Colombian soldiers killed in guerrilla attack: army
-
Amorim takes aim at Man Utd youth stars over 'entitlement'
-
Mercosur meets in Brazil, EU eyes January 12 trade deal
-
US Fed official says no urgency to cut rates, flags distorted data
-
Rome to charge visitors for access to Trevi Fountain
C2Dx Announces Rebrand to Everis Medical, Marking a New Era of Growth
KALAMAZOO, MI / ACCESS Newswire / May 5, 2025 / C2Dx, a leading medical device company known for acquiring and revitalizing essential, underserved technologies, is proud to announce its rebrand to Everis. This transformation reflects the company's continued commitment to elevating possibilities in healthcare, expanding its focus, and propelling impactful surgical technologies forward.
Founded in 2019 by industry experts, C2Dx was built on the belief that proven medical devices still have untapped potential to serve patients and providers. Now, as Everis, the company embraces a name that evokes endurance (ever), progress (evolving), and energy (life force)-capturing the spirit of continuous innovation and purpose-driven growth.
"Everis represents who we are becoming," said Sarah Hollingsworth, Vice President of Marketing. "We're not only preserving the legacy of essential technologies-we're building their future. Our new identity reflects our mission to redefine what's possible in patient care."
While the name is new, the company's dedication remains unchanged: providing exceptional customer support, trusted solutions, and a relentless focus on enhancing outcomes.
"Our evolution into Everis reflects more than a name change-it's a signal of our long-term growth trajectory," said Kevin McLeod, CEO. "We're actively building a portfolio of transformative technologies, and we see corporate development as a vital path to scale our impact. Whether through strategic partnerships or acquisitions, we're focused on expansion and growth."
Everis will debut its new branding at COSM 2025, inviting physicians to experience what's next.
For more information, visit everismedical.com.
Media Contact:
Sarah Hollingsworth
Vice President of Marketing
Everis Medical
[email protected]
everismedical.com
SOURCE: Everis
View the original press release on ACCESS Newswire
B.Torres--AT